Pharmacology & ToxicologybioRxivPreprint
Losartan promotes cell survival following SARS-CoV-2 infection in vitro
R. Nejat, A. S. Sadr, B. T. Freitas…·D. J. Najafi
This study shows that Losartan reduces SARS-CoV-2 replication in Vero E6 cells by 80% pre-infection and 70% post-infection, promoting cell survival with low side-effects.
DOI 10.1101/2020.12.27.424507